Liver Diseases Clinical Trials

15 recruiting

Frequently Asked Questions

Common questions about Liver Diseases clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 115 of 15 trials

Recruiting
Not Applicable

Veteran-Centered Care for Advanced Liver Disease (Vet-CALD)

Liver Diseases
VA Office of Research and Development450 enrolled8 locationsNCT06068491
Recruiting

Prediction of Decompensation and HCC Development in Advanced Chronic Liver Disease

Hepatocellular CarcinomaHepatocarcinomaLiver Diseases+1 more
University Hospital Muenster600 enrolled1 locationNCT06523608
Recruiting
Not Applicable

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Insulin Sensitivity/ResistanceObesityInsulin Resistance+16 more
Pichamol Jirapinyo, MD, MPH132 enrolled2 locationsNCT06138821
Recruiting

Liver Disease and Other Systemic Diseases

Hepatocellular CarcinomaHumansTreatment Outcome+7 more
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation15,000 enrolled1 locationNCT04525833
Recruiting
Phase 4

The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine

Hepatocellular Carcinoma (HCC)Liver Diseases
Anhui Provincial Hospital96 enrolled1 locationNCT07150624
Recruiting
Phase 1Phase 2

CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection

Liver CancerLiver MetastasesLiver Cirrhosis+4 more
AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC90 enrolled1 locationNCT07053488
Recruiting
Not Applicable

Hepatic and Systemic Hemodynamic Modeling During Liver Surgery

Liver DiseasesLiver Transplantation
Assistance Publique - Hôpitaux de Paris150 enrolled1 locationNCT05339984
Recruiting

Observational Pharmaco-Epidemiology Research & Analysis

Cardiovascular DiseasesInflammatory Bowel DiseasesLiver Diseases+4 more
Epividian2,000,000 enrolled1 locationNCT03813862
Recruiting
Phase 3

Noninvasive Subharmonic Aided Pressure Estimation of Portal Hypertension; Renewal

Liver DiseasesPortal Hypertension
Thomas Jefferson University660 enrolled3 locationsNCT05470205
Recruiting
Phase 4

Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose

Liver DiseasesCirrhosis, LiverPortal Hypertension+2 more
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)238 enrolled6 locationsNCT04073290
Recruiting
Not Applicable

bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC

Hepatocellular CarcinomaImmunotherapyCamrelizumab+2 more
Sun Yat-sen University40 enrolled1 locationNCT06061276
Recruiting
Not Applicable

bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma

Hepatocellular CarcinomaImmunotherapySintilimab+2 more
Sun Yat-sen University30 enrolled1 locationNCT06070636
Recruiting

Perioperative Energy Expenditure in Major Liver Resection

CancerLiver NeoplasmsLiver Diseases
Academisch Ziekenhuis Maastricht20 enrolled1 locationNCT05931068
Recruiting

Major Hepatectomy and Vascular Clamping

Liver Diseases
University Hospital, Strasbourg, France100 enrolled1 locationNCT06501742
Recruiting

Design and Implementation of the Pediatric Liver Transplantation Biobank

Liver Transplant; ComplicationsPediatric ALLLiver Diseases
Children's Hospital of Chongqing Medical University500 enrolled1 locationNCT04477967